Key result
Silencing lncRNA NONMMUT002434 halts hypoxia-induced aortic smooth muscle cell migration.
Why the study?
The aberrant expression of long noncoding RNAs in hypoxic vascular smooth muscle cells and their role in atherosclerosis development is not well investigated.
Hypoxia alters lncRNA and mRNA expression profiles in vascular smooth muscle cells, with lncRNA NONMMUT002434 identified as a key regulator of cell migration and proliferation in atherosclerosis.
Hypothesis-generating in murine VSMC hypoxia; leaves open lncRNA NONMMUT002434 as a vascular target pending human validation.
Hypoxia may cause abnormal proliferation and migration of the vascular smooth muscle cells (VSMCs) from the media to the intima. This contributes to vessel narrowing and accelerates the process of atherosclerosis. The association of the aberrant expression of long noncoding RNAs (lncRNAs) with the development and progression of atherosclerosis is well known; however, it is not well investigated in hypoxic VSMCs. Using a microarray approach, we identified 1056 and 2804 differentially expressed lncRNAs and mRNAs, respectively, in hypoxic and normoxic mouse aorta smooth muscle (MOVAS) cells. Of them, we randomly chose several lncRNAs and validated the microarray data using the quantitative PCR (qPCR) assay. Advanced bioinformatics analyses indicated that the up-regulated mRNAs were mainly involved in inflammatory responses, lipid metabolism, clearance of amyloid-β peptide, citrate cycle (TCA cycle), TGF-β signaling, and chemokine signaling. The down-regulated mRNAs were mainly involved in the apoptosis pathway, glycerolipid metabolism, Wnt signaling pathway, and MAPK signaling pathway. The constructed coexpression network indicated interactions between 87 lncRNAs and ten mRNAs. In addition, we demonstrated that the silence of lncRNA NONMMUT002434 expression could abrogate the migration and proliferation of smooth muscle cells dramatically. Our data provide comprehensive evidence on the differential expression of lncRNAs and mRNAs in hypoxic MOVAS cells, which may be valuable biomarkers for atherosclerotic diseases, and thereby facilitating diagnosis of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2019) studied Atherosclerosis. Hypoxia vs. Normoxia was evaluated on Differentially expressed lncRNAs and mRNAs. Hypoxia in mouse aorta smooth muscle cells resulted in 1056 differentially expressed lncRNAs and 2804 mRNAs compared to normoxia, and silencing lncRNA NONMMUT002434 abrogated cell migration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: